Tag: Generics
Physicians lack consensus on patient choice between branded and generic drugs,...
Understanding these dynamics is pivotal for promoting informed decision-making and improving patient outcomes in medication management, according to the survey
Lupin appoints Dr Shahin Fesharaki as Global CSO
Dr. Fesharaki will be responsible for Lupin’s global research and development efforts across branded, generics and specialty products
Pricing pressures & regulatory scrutiny persist in US generics pharma industry:...
Some major Indian pharmaceutical companies reported sizeable impairment losses and also announced discontinuation of some products or segments due to lower earnings potential
India tops the chart for approved biosimilars & clinical trials surpassing...
The recent acts and policy changes like the Generic Drug User Fee Act (GDUFA) is expected to positively impact the generics manufacturers in India, deliberations at Pharma IPR India Conference revealed ..................................
India’s pharma industry & academia join hands to catalyze innovation in...
At the first CSIR-IPA Pharma Innovation Exchange Forum, the scientists come together to stimulate industry and academia exchange on pharmaceutical innovation knowledgebase and to forge future collaborations......................
Jubilant launches JUBI-R, its generic version of COVID-19 drug remdesivir in...
Jubilant Generics, a subsidiary of Jubilant Life Sciences has launched remdesivir for injection under the brand name ‘JUBI-R’ in the Indian market at a price of INR 4,700 per vial of 100 mg (lyophilized injection)........................
Dr Reddy’s Laboratories gets a new COO
Mr Erez Israeli, former President & CEO of Enzymotec has joined Dr Reddy’s Laboratories on April 2, 2018, as Chief Operating Officer and Global Head of Generics & PSAI, based out of Hyderabad...........
Amneal & Impax merger to create 5th biggest pharma generics firm...
Combined company to benefit from expanded generics product portfolio, premier diversified generics pipeline, broad R&D capabilities across dosage forms, high-quality and low-cost global manufacturing and distribution network, and enhanced financial foundation........
We must strive to be a leader in biotech drug discovery,...
Listing out his mantra for science and entrepreneurship, the Prime Minister, Mr Narendra Modi during in his inaugural address at the Nobel Prize Series at Ahmedabad, exhorted the scientists to work towards making India a biotech hub....
CSIR to showcase technologies at 14 day long ‘Platinum Jubilee Techno...
The event was inaugurated by the union science and technology minister, Dr Harsh Vardhan at the India International Trade Fair (IITF) in New Delhi on 14th November.....